CVE:IBT IBEX Technologies (IBT) Stock Price, News & Analysis → Reclusive millionaire’s final warning about America (From Weiss Ratings) (Ad) Free IBT Stock Alerts C$1.44 0.00 (0.00%) (As of 04/5/2024) Add Compare Share Share Today's RangeC$1.44▼C$1.4450-Day RangeC$1.44▼C$1.4452-Week RangeC$0.75▼C$1.45Volume200 shsAverage Volume68,888 shsMarket CapitalizationC$35.29 millionP/E Ratio9.60Dividend Yield3.11%Price TargetN/A Stock AnalysisStock AnalysisChartEarningsStock AnalysisChartEarnings Get IBEX Technologies alerts: Email Address Ad Weiss RatingsReclusive millionaire’s final warning about AmericaThis crisis that's likly to begin in this country — before the election — could be bigger and more destructive than any crisis I've ever seen. That's why, no matter what you do, make sure you watch my short video and learn the three steps you need to take right now.Click here to learn how to prepare before it's too late. About IBEX TechnologiesIBEX Technologies Inc., through its subsidiaries, manufactures and markets enzymes for biomedical use in Canada, the United States, Germany, the United Kingdom, and internationally. It offers a portfolio of recombinant glycosaminoglycan lyases, including Heparinase I, Heparinase II, Heparinase III, Chondroitinase AC, and Chondroitinase B; collagen ELISAs for the study of synthesis and degradation of connective tissue components; collagen antibodies; and diamine oxidase liquid. The company also manufactures and markets a range of arthritis assays, which are used in osteoarthritis research. In addition, it provides lyophilization services for making disposable medical device components; and custom fermentation and contract manufacturing services. It serves manufacturers of medical devices, quality control labs, low molecular weight heparin manufacturers, and academic research institutions. IBEX Technologies Inc. was incorporated in 1972 and is based in Montreal, Canada.Read More IBT Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart IBT Stock News HeadlinesMay 2, 2024 | tmcnet.comibex's Christy O'Connor Recognized as Top 10 Corporate Counsel Award WinnerApril 8, 2024 | markets.businessinsider.comIBEX Completes Sale of the CompanyJune 18, 2024 | Weiss Ratings (Ad)Reclusive millionaire’s final warning about AmericaThis crisis that's likly to begin in this country — before the election — could be bigger and more destructive than any crisis I've ever seen. That's why, no matter what you do, make sure you watch my short video and learn the three steps you need to take right now.April 4, 2024 | finanznachrichten.deIBEX Technologies Inc.: IBEX Shareholders Approve Sale of the CompanyMarch 23, 2024 | wsj.comIBEX Technologies Inc.March 14, 2024 | finance.yahoo.comIBEX Files Addendum to Management Proxy Circular for Sale of the Company at $1.45 Per ShareJanuary 1, 2024 | investing.comIBEX Technologies Inc (IBT) Earnings Dates & ReportsOctober 18, 2023 | theglobeandmail.comClosing Bell: Ibex Technologies Inc flat on Wednesday (IBT)June 18, 2024 | Weiss Ratings (Ad)Reclusive millionaire’s final warning about AmericaThis crisis that's likly to begin in this country — before the election — could be bigger and more destructive than any crisis I've ever seen. That's why, no matter what you do, make sure you watch my short video and learn the three steps you need to take right now.October 6, 2023 | theglobeandmail.comClosing Bell: Ibex Technologies Inc flat on Thursday (IBT)September 26, 2023 | theglobeandmail.comClosing Bell: Ibex Technologies Inc down on Thursday (IBT)August 3, 2023 | theglobeandmail.comClosing Bell: Ibex Technologies Inc up on Tuesday (IBT)June 15, 2023 | finance.yahoo.comIs IBEX Technologies Inc.'s (CVE:IBT) Recent Stock Performance Tethered To Its Strong Fundamentals?June 14, 2023 | baystreet.caMayfair Hits 52-Week High on NewsMay 23, 2023 | ca.finance.yahoo.comIBEX Technologies Inc. (IBT.V)May 9, 2023 | theglobeandmail.comClosing Bell: Ibex Technologies Inc up on Friday (IBT)April 22, 2023 | theglobeandmail.comClosing Bell: Ibex Technologies Inc down on Friday (IBT)April 6, 2023 | theglobeandmail.comClosing Bell: Ibex Technologies Inc down on Wednesday (IBT)March 22, 2023 | finance.yahoo.comCalculating The Intrinsic Value Of IBEX Technologies Inc. (CVE:IBT)January 23, 2023 | baystreet.caAg Growth, ATEX, IBEX at 52-Week HighsSeptember 14, 2022 | finance.yahoo.comIbex Technologies Inc (IBT.BE)January 5, 2022 | investing.comIBEX Technologies Inc (IBT)November 13, 2021 | yahoo.comBig Country 11-man high school football scores, schedules 2021November 13, 2021 | yahoo.comBig Country six-man high school football scores, schedules 2021See More Headlines Receive IBT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for IBEX Technologies and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeCVE SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolCVE:IBT CUSIPN/A CIKN/A Webwww.ibex.ca Phone+1-514-3444004FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)C$0.15 Trailing P/E Ratio9.60 Forward P/E RatioN/A P/E GrowthN/ANet IncomeC$3.98 million Net Margins49.70% Pretax MarginN/A Return on Equity32.13% Return on Assets6.42% Debt Debt-to-Equity Ratio11.06 Current Ratio6.24 Quick Ratio4.93 Sales & Book Value Annual SalesC$8 million Price / Sales4.41 Cash FlowC$0.92 per share Price / Cash Flow1.56 Book ValueC$0.58 per share Price / Book2.48Miscellaneous Outstanding Shares24,510,000Free FloatN/AMarket CapC$35.29 million OptionableNot Optionable Beta-0.05 10 "Recession Proof" Stocks That Will Thrive in Any MarketWhich stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.Get This Free Report Key ExecutivesMr. Paul Baehr (Age 81)President, CEO & Chairman Comp: $406.2kBelinda Franco C.A.CPA, CFO, VP of Finance & Administration and SecretaryMr. Mahendra Kumar PallapothuVice President of OperationsKey CompetitorsOncolytics BiotechTSE:ONCScythian BiosciencesCVE:SCYB138267 (COM.TO)TSE:COMNovoheartCVE:NVHSernovaTSE:SVAView All Competitors IBT Stock Analysis - Frequently Asked Questions How have IBT shares performed in 2024? IBEX Technologies' stock was trading at C$1.19 at the start of the year. Since then, IBT shares have increased by 21.0% and is now trading at C$1.44. View the best growth stocks for 2024 here. What other stocks do shareholders of IBEX Technologies own? Based on aggregate information from My MarketBeat watchlists, some companies that other IBEX Technologies investors own include Acerus Pharmaceuticals (TRLPF), Air Canada (AC), American Airlines Group (AAL), Cognex (CGNX), Baytex Energy (BTE), Bank of Montreal (BMO), Antares Pharma (ATRS), Algonquin Power & Utilities (AQN) and AJA.AX (AJA). How do I buy shares of IBEX Technologies? Shares of IBT stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. This page (CVE:IBT) was last updated on 6/18/2024 by MarketBeat.com Staff From Our PartnersAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredBiden to Launch “FedNOW” [Move Your Money Now]Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentia...Priority Gold | SponsoredBigger Than NVIDIA?With NVIDIA flying high, everyone is looking for the next breakout stock. But right now... There's only ...Behind the Markets | SponsoredBeta testers blew this thing upThis AI trading tool is probably unlike anything you've ever seen before… It scans the entire market and fi...Prosper Trading Academy | SponsoredRadical change coming — do this NOW to protect yourselfI recently uncovered a way the government could use the next crisis as a pretext to gain more control … and ra...Weiss Ratings | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | SponsoredWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredThe #1 Crypto That You Don’t Own… YetThere’s all kinds of “signals” to follow when investing in cryptos. But there’s one signal you should pay a...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IBEX Technologies Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share IBEX Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.